<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate the role of plasma <z:chebi fb="23" ids="18059">lipid</z:chebi> abnormalities in ischemic cerebrovascular disease related to primary vessel disease, the authors assess <z:chebi fb="23" ids="18059">lipid</z:chebi> profiles in a hospital-based cohort of 202 consecutive patients with atherothrombotic or lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo> subtypes </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="1" ids="6495">Lipoprotein</z:chebi> (a) was the unique <z:chebi fb="23" ids="18059">lipid</z:chebi> parameter that differs between these two subtypes being its value twofold higher in patients with atherothrombotic than in lacunar <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>This suggests that <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (a) promotes large vessel <z:hpo ids='HP_0002635'>atheromatosis</z:hpo> rather than small vessel <z:e sem="disease" ids="C0878486" disease_type="Disease or Syndrome" abbrv="">arteriolosclerosis</z:e> and favors <z:mp ids='MP_0005048'>thrombosis</z:mp> on atheromatous plaques by suppressing local fibrinolysis </plain></SENT>
</text></document>